Immunophenotyping and Xist Gene in AML
Condition(s):Acute Myeloid LeukemiaLast Updated:July 9, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:July 9, 2020Not yet recruiting
Condition(s):DLBCL; MYD88 Gene Mutation; CD79A Gene Mutation; CD79B Gene Mutation; Relapse; Refractory LymphomaLast Updated:August 6, 2021Not yet recruiting
Condition(s):Neonatal Seizure; Hypoxic-Ischemic Encephalopathy; Stroke; Intracranial Hemorrhage; Epilepsy; Gene AbnormalityLast Updated:May 4, 2022Recruiting
Condition(s):Pancreatic CancerLast Updated:January 19, 2021Completed
Condition(s):Pre-mutation on FMR1 GeneLast Updated:December 10, 2012Terminated
Condition(s):Arteriovenous MalformationsLast Updated:March 7, 2022Recruiting
Condition(s):Chiari Malformation, Type 1Last Updated:December 21, 2021Not yet recruiting
Condition(s):Primary Raynaud’s Phenomenon (PR); Genetic Mutations Causing PR; Study of Patients and Their Relatives (With or Without Primary PR)Last Updated:June 24, 2020Completed
Condition(s):Systemic SclerosisLast Updated:June 24, 2005Unknown status
Condition(s):Heart Septal Defects, Ventricle; Heart Defects, Congenital; Double Outlet Right Ventricle; Truncus Arteriosus, PersistentLast Updated:July 2, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.